St Lawrence Health running trial of lupus treatment northcountrynow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from northcountrynow.com Daily Mail and Mail on Sunday newspapers.
CANTON — St. Lawrence Health’s Clinical and Rural Health Research Department is currently conducting a TULIP (Treatment of Uncontrolled Lupus via the Interferon Pathway) clinical trial being sponsored by AstraZeneca.
Saphnelo approved in EU for treatment of moderate to severe systemic lupus erythematosus miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE), despite receiving standard therapy. Saphnelo is the first biologic for SLE approved in .